Ligand validation:3PEU

IHP: INOSITOL HEXAKISPHOSPHATE

IHP is a Ligand Of Interest in 3PEU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3PEU_IHP_B_1003	78%	24%	0.129	0.972	1.34	1.95	3	13	1	0	100%	1
3RRM_IHP_B_1	77%	26%	0.129	0.969	1.29	1.85	4	14	0	0	100%	1
3PEV_IHP_B_1003	72%	21%	0.137	0.961	1.35	2.11	4	12	1	0	100%	1
3RRN_IHP_B_1	49%	24%	0.183	0.931	1.35	1.89	3	16	0	0	100%	1
1ZY7_IHP_A_901	99%	48%	0.055	0.989	0.99	1.03	2	2	0	0	100%	1
3HO6_IHP_A_270	97%	29%	0.072	0.985	2.06	0.91	15	2	0	0	100%	1
4LV7_IHP_A_501	92%	41%	0.093	0.986	1.11	1.25	1	6	0	0	100%	1
3EEB_IHP_B_210	92%	52%	0.091	0.983	0.86	1.01	-	-	0	0	100%	1
3PEE_IHP_B_256	91%	49%	0.099	0.988	0.87	1.1	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.